Intelligent Bio Solutions Inc. (INBS) Cost of Revenue (2022 - 2025)

Intelligent Bio Solutions' Cost of Revenue history runs 4 years deep, the most recent figure standing at $387499.0 for Q1 2025.

• In Q1 2025, Cost of Revenue fell 39.95% year-over-year to $387499.0; the TTM figure through Mar 2025 stood at $1.9 million (down 10.37% YoY), while the FY2023 annual figure was $930204.0, changed N/A from the prior year.
• Cost of Revenue for Q1 2025 stood at $387499.0, up from $384381.0 in the prior quarter.
• The five-year high for Cost of Revenue was $645311.0 in Q1 2024, with the low at $112635.0 in Q4 2022.
• The 4-year median for Cost of Revenue is $424009.0 (2023), against an average of $444606.6.
• The sharpest annual moves came in 2023 and 2025: Cost of Revenue jumped 401.46% in 2023, then slumped 39.95% in 2025.
• Intelligent Bio Solutions' Cost of Revenue stood at $112635.0 in 2022, then surged by 401.46% to $564815.0 in 2023, then tumbled by 31.95% to $384381.0 in 2024, then increased by 0.81% to $387499.0 in 2025.
• Business Quant data shows INBS's Cost of Revenue at $387499.0 in Q1 2025, $384381.0 in Q4 2024, and $525486.0 in Q3 2024.